Gilead’s HIV breakthrough, Lilly’s $1.3B gene editing deal, and FDA reform efforts (June 13–19, 2025).
HIV Breakthrough & Gene Editing Deals — This…
Gilead’s HIV breakthrough, Lilly’s $1.3B gene editing deal, and FDA reform efforts (June 13–19, 2025).